baber/WOPTO huggingface dataset:
Patent NZ-584353-A (NZ)
Title: Wall block with weight bearing pads and method of producing wall blocks
Inventor: LACROIX DAVID
IPC: B28B3/02
Filed: 2008-11-07
Abstract: Disclosed is a wall block having at least two weight bearing pads on an upper or lower surface of the block, compression head and methods of making the block and making walls with the block. The block has the pads extending from upper or lower surfaces from a front face to two respective second rear faces.
Patent NZ-585969-A (NZ)
Title: Fluorometric method for monitoring surface additives in a papermaking process
Inventor: THOMAS JAMES L
IPC: D21H21/30
Filed: 2008-11-14
Abstract: A method of monitoring and optionally controlling the addition of one or more surface additives to a papermaking process to form a coating on a sheet comprising the following steps: a. adding a known amount of one or more surface additives to a papermaking process either alone or in known proportion with a known amount of one or more inert fluorescent tracers, wherein the surface additives can only be added alone when the surface additives are capable of fluorescing; b. measuring the fluorescence of the surface additives and/or one or more inert fluorescent tracers at a point subsequent to adding the surface additives and after a sheet has been formed, wherein the surface additives can only be measured when they are capable of fluorescing and wherein fluorescence is measured with a reflectance based fluorometer; c. correlating the amount of fluorescence of the surface additives when they are capable of fluorescing and/or inert fluorescent tracers on a sheet with the concentration of the surface additives in a coating on a sheet and/or thickness of a coating on a sheet; and d. controlling the addition of one or more surface additives to a papermaking process by adjusting the amount of the surface additives added to the papermaking process in response to the coating thickness on a sheet and/or concentration of the surface additives in a coating on a sheet, wherein one or more controllers are in communication with the fluorometer and are programmed with an algorithm to collect said fluorescence measurements, correlate the amount of fluorescence of the surface additives and/or inert fluorescent tracers on a sheet and/or thickness of a coating on a sheet, and adjust the amount of the surface additives added to the papermaking process, adjust paper machine operating parameters, adjust setting of a puddle type or metering size press, or a combination thereof in response to the coating thickness on a sheet and/or concentration of the surface additives in a coating on a sheet in accord with a pre-determined protocol, wherein the surface additives are selected from the group consisting of at least one of the following: starch, binders, plasticizers, and other additives to improve the physical properties of a paper/board sheet, including surface strength, , printability, water resistance, adhesion of subsequent coatings.
Patent NZ-597037-A (NZ)
Title: Connector for holding resilient tube between annular inner and outer portions with inner portion tapering outwardly from a head connection
Inventor: MOORE SIMON GARRY
IPC: F16L33/22
Filed: 2010-11-17
Abstract: The connector has inner and outer portions between which an entry passage is created that has a constricting region of lesser width than that of an elastic tube to be inserted into the passage. The inner portion tapers outwardly from a head connection so that as a force is applied to the tube away from the connector a resistance force is created.
Patent NZ-601018-A (NZ)
Title: Ev576 for use in the treatment of viral infections of the respiratory tract
Inventor: WESTON-DAVIES WYNNE
IPC: A61K38/16
Filed: 2011-01-10
Abstract: Disclosed are methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A HlNl (swine 'flu).
Patent NZ-601594-A (NZ)
Title: Treatment of respiratory disorders
Inventor: CAPARROS-WANDERLEY WILSON
IPC: A61P29/00
Filed: 2011-02-04
Abstract: This disclosure relates to the treatment of respiratory disorders, and in particular respiratory disorders and oedema caused by pathogenic infections. In particular, the disclosure relates to orally administrable pharmaceutical compositions for treating respiratory disorders, and to methods of such treatment. The invention is particularly concerned with the treatment of respiratory disorders that are caused by viral infections, such as with influenza viral strains. The disclosure also extends to analgesic compositions and methods for treating inflammatory pain manifesting in a variety of diseases, and not only respiratory diseases. NSAIDs that may be used in the disclosed formulations include: Alminoprofen; Benoxaprofen; Dexketoprofen; Flurbiprofen; Ibuprofen; Indoprofen; Ketoprofen; Loxoprofen; Pranoprofen; Protizinic acid; Suprofen; Aceclofenac; Acemetacin; Actarit; Alcofenac; Amfenac; Clometacin; Diclofenac; Etodolac; Felbinac; Fenclofenac; Indometacin; Ketorolac; Metiazinic acid; Mofezolac; Naproxen; Oxametacin; Sulindac; Zomepirac; Celecoxib; Etoricoxib; Lumiracoxib; Meloxicam; Rofecoxib; Valdecoxib; Aloxipirin; Aminophenazone; Antraphenine; Aspirin; Azapropazone; Benorilate; Benzydamine; Butibufen; Chlorthenoxacin; Choline Salicylate; Diflunisal; Emorfazone; Epirizole; Feclobuzone; Fenbufen; Glafenine; Hydroxylethyl salicylate; Lactyl phenetidin; Mefenamic acid; Metamizole; Mofebutazone; Nabumetone; Nifenazone; Niflumic acid; Phenacetin; Pipebuzone; Propyphenazone; Proquazone; Salicylamide; Salsalate; Tiaramide; Tinoridine; and Tolfenamic acid.
Patent NZ-609840-A (NZ)
Title: Process for making multiparticulate gastroretentive dosage forms
Inventor: KIRKORIAN JOËL SYLVAIN MICHEL
IPC: A61K31/717
Filed: 2011-10-20
Abstract: Disclosed is a method for making low density particles, comprising the steps of (i) providing a powder mixture comprising a swelling agent; (ii) granulating the powder of step (i) with a granulating solution comprising a lipophilic agent into granules; (iii) drying the granules of step (ii). The process may further include coating the granules, adding in an active ingredient and/or a binder. The swelling agent may be a cellulose derivative, the lipophilic agent may be hydrophobic dusty powders and lipidic excipients, preferably from the group consisting of talc, hydrophobic silica, magnesium stearate, glicerides, fatty acid esters or fatty acid, preferably talc, stearic acid glicerides and mixtures thereof and the granulating solution may be an aqueous solution or dispersion an organic solvent, a hydrophobic liquid or water, preferably water. The particle may be further processed into an oral solid gastro-retentive dosage form, such as a tablet, capsule or a sachet.
Patent NZ-612894-A (NZ)
Title: Agricultural compositions comprising oil-in-water emulsions
Inventor: TANK HOLGER
IPC: B01F3/08
Filed: 2012-01-12
Abstract: Disclosed herein is an oil-in-water emulsion composition having at least one agriculturally active compound, the oil-in-water emulsion composition comprising: A) an oil phase, wherein the oil phase comprises at least one agriculturally active ingredient, said oil phase comprising oily globules, the oily globules having a mean particle diameter of less than about 800 nanometers; and B) an aqueous phase, wherein the oily globules are dispersed in the aqueous phase and wherein at least some of the oily globules dispersed in the aqueous phase are coated with a polymeric adsorption layer, wherein said polymeric adsorption layer consists of: (1) at least one polymeric surface-active agent having an HLB value in the range of about 16 to about 18; and (2) at least one ionic surface-active agent.Agriculturally active ingredients that can be used with the emulsion include, pesticides, herbicides, fungicides, mitocides, bactericides and the like. Also disclosed are methods of using the oil-in-water emulsions to treat plants and on surfaces adjacent to plants, plant pests or other pests.
Patent NZ-618948-A (NZ)
Title: Polymers and plastics derived from animal proteins
Inventor: BRESSLER DAVID CURTIS
IPC: C08L89/00
Filed: 2012-05-14
Abstract: Disclosed is a method for preparing a polymer derived from an animal protein, such as in a feedstock derived from animal by-products. The method involves hydrolysing proteins present in a feedstock to obtain a hydrolysed protein mixture, wherein hydrolysis is conducted under thermal or alkaline conditions sufficient to digest the proteins and destroy pathogens; extracting a protein fraction from the hydrolysed protein mixture; and treating the protein fraction with a crosslinking reagent to form the polymer; wherein the crosslinking reagents are selected from glutaraldehyde, glyoxal, resorcinol, benzaldehyde, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, N-hydroxysuccinimide, N,N-dicyclohexylcarbodiimide, diglycidyl ether of bisphenol A, aliphatic polyglycol epoxy, or resorcinol diglycidyl ether. The polymer may be further processed to form a thermoset plastic suitable for use as an adhesive, or in the preparation of a natural fiber composite material.
Patent NZ-630754-A (NZ)
Title: Positioning and stabilising structure for a patient interface system
Inventor: DUNN JESSICA LEA
IPC: A61M16/06
Filed: 2013-11-15
Abstract: A patient interface system to treat sleep disordered breathing of a patient with pressurized gas, comprising: a patient interface (3301); at least one strap (3308); at least one retractor (3304) fixedly attached to the patient interface, the at least one retractor connected to the at least one strap and configured to retract the at least one strap without patient actuation; and at least one pad (3302) to cushion a rearward portion of the patient’s head. The at least one pad has an opening, the at least one strap passing through the opening to allow the at least one pad to move freely relative to the at least one strap.
Patent NZ-631408-A (NZ)
Title: C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity
Inventor: REGUEIRO-REN ALICIA
IPC: C07J63/00
Filed: 2013-02-13
Abstract: Disclosed are C-3 cycloalkenyl triterpenoid compounds of formula (I)-(IV), wherein the substituents are as defined in the specification. The compounds possess antiviral activity and are HIV maturation inhibitors useful for the treatment of HIV and AIDS. An example of a compound of formula (I)-(IV) is: 2-(4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11apentamethyl-3a-((2-(4-(methylsulfonyl)piperidin-1-yl)ethyl)amino )-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1Hcyclopenta[a]chrysen-9-yl)cyclohex-3-en-1-yl)acetic acid
Patent NZ-718192-A (NZ)
Title: Veterinary formulations and methods
Inventor: DOUGLAS GRANT HALLIGAN
IPC: C07D493/22
Filed: 2013-10-07
Abstract: Disclosed herein are methods and formulations for the anthelmintic treatment of non-human animals with at least two macrocyclic lactones wherein; at least one of the macrocyclic lactones is a milbemycin and at least one of the macrocyclic lactones is an avermectin; the milbemycin compounds are selected from the group consisting of moxidectin, milbemycin oxime, nemadectin, and milbemectin; and the avermectin compounds are selected from the group consisting of abamectin, ivermectin, eprinomectin, doramectin, selamectin, and emamectin. Also disclosed are methods and formulations for treating, reducing or preventing the incidence of a parasite in a non-human animal or improving the treatment of pathogenic and/or resistant worm strain by administering to the non-human animal an effective amount of at least two of said milbemycin and avermectin macrocyclic lactones.
Patent NZ-723576-A (NZ)
Title: Electrolyte purgatives
Inventor: BORODY THOMAS
IPC: A61P1/10
Filed: 2012-10-27
Abstract: The disclosure provides compositions for use in purgatives, for use as purgatives, and to methods for inducing purgation of the colon. The composition comprising between 1 and 20 grams of at least one water-soluble sodium salt; between 0.1 and 4.8 grams of at least one water-soluble potassium salt; between 0.1 and 7 grams of at least one water-soluble magnesium salt; erythritol; and a bisoxatin (or 2,2-bis(4-hydroxyphenyl)-2H-benzo[b][1,4]oxazin-3(4H)-one), or bisoxatin acetate, or equivalent. In alternative embodiments, the disclosure provides compositions, e.g., a purgative, comprising: a water-soluble sodium salt (especially sodium sulphate), a water-soluble potassium salt (especially potassium sulphate), and a water-soluble magnesium salt (especially magnesium sulphate); and, compositions further comprising: a bisoxatin, or a detergent stool softening agent (such as sodium picosulphate) and/or a water-soluble sugar (such as xylose or equivalent); or, compositions having these ingredients at different amounts, but at equivalent proportions. In alternative embodiments, the disclosure provides purgative compositions comprising electrolytes, salts, sugars, bisoxatin, dyes and biofilm disruptors. An example of a composition comprises bisoxatin, sodium, potassium and magnesium electrolytes and erythritol.
Patent NZ-730611-A (NZ)
Title: Antibody capable of neutralizing substance having activity alternative to function of coagulation factor viii (fviii)
Inventor: IGAWA TOMOYUKI
IPC: C12N5/10
Filed: 2015-09-24
Abstract: It is tried to produce an antibody capable of neutralizing the activity of a substance having an activity alternative to the function of FVIII, for the purpose of using the antibody in a method for measuring the reactivity of FVIII in the presence of the substance having the activity alternative to the function of FVIII. As the result, it is found that, when the produced antibody is used, the activity of FVIII in plasma from a hemophilia A patient can be evaluated accurately in an APTT-based one-stage clotting assay. It is also found that, when the produced antibody is used, the titer of an FVIII inhibitor in plasma from an FVIII inhibitor-carrying hemophilia A patient can be evaluated accurately in an APTT-based Bethesda assay.
Patent NZ-738077-A (NZ)
Title: Method of production of a silica concentrate
Inventor: MITCHELMORE ANDREW W
IPC: C02F1/60
Filed: 2016-06-20
Abstract: The invention relates to methods of production of a silica concentrate from geothermal fluids. More particularly, although not exclusively, the invention relates to the production of a colloidal silica concentrate, colloidal silica or precipitated silica from high temperature geothermal fluids by ultrafiltration to produce size-specific silica colloids and step-wise concentration of silica to avoid precipitation or gelling.
Patent NZ-747569-A (NZ)
Title: Sea wall structures, sea walls and methods of manufacture and assembly of the same
Inventor: HAIGH PETER
IPC: E02D29/02
Filed: 2017-04-28
Abstract: A sea wall structure (10) comprising a rigid supporting structure (12) and one or more hollow tanks (14) affixed to the supporting structure (12), wherein the volume of the tank or tanks (14) is such that, when filled with air, their displacement is sufficient to support the weight of the sea wall structure (10) and thus enable the sea wall structure to be floated on water (300). The rigid supporting structure (12) is suitably made from cast, reinforced concrete, and the tank or tanks (14) are suitably blow-moulded plastics components having peripheral edges that are moulded into the concrete.The sea wall structure (10) is ideally modular, having side edges that are adapted (28, 30) to engage with adjacent structures (10) to form a wall, caisson or the like.
Patent NZ-747740-A (NZ)
Title: Enlargeable flexible hose
Inventor: MEZZALIRA ALESSANDRO
IPC: F16L11/04
Filed: 2016-04-29
Abstract: A flexible hose for transporting water, which is enlargeable, i. e. susceptible to automatically enlarge upon the passage of the fluid inside it and to automatically retract when the pressure of the liquid stops. The problem of other flexible hoses is that they are difficult to manufacture, heavy and bulky, the solution of the invention is to provide an enlargeable flexible hose of remarkable efficiency and relative cheapness. A hose assembly for transporting liquids, comprising: an enlargeable flexible hose; and a restriction placed within the hose or connected to the hose to create a working pressure therein to promote an enlargement of the flexible hose, wherein the flexible hose includes: an inner layer made of a first elastic polymeric material; an outer layer made of a second elastic polymeric material; and a single textile reinforcement layer interposed between the inner layer and the outer layer; wherein the inner layer and the outer layer are reciprocally coupled to form a unitary tubular member having an original outer diameter; wherein the unitary tubular member has an elasticity that causes the unitary tubular member to automatically enlarge under the working pressure imparted by a liquid flowing therethrough without increasing in length more than 15%, so as to increase the original outer diameter of the unitary tubular member and have an automatic recovery once the working pressure stops and assume again the original outer diameter; wherein the textile reinforcement layer is embedded within the unitary tubular member to move between a rest configuration that the textile reinforcement layer has when no liquid flows through the unitary tubular member, and a working configuration that the textile reinforcement layer has when the unitary tubular member enlarges upon the working pressure; and wherein the textile reinforcement layer consists of non-elastic yarns having an elongation at break of less than 30%.
Patent NZ-752214-A (NZ)
Title: Arsenic compositions
Inventor: EUTICK MALVIN
IPC: A61K33/36
Filed: 2017-08-02
Abstract: The present invention is predicated on the realisation that problems with the poor water solubility of arsenic trioxide and the extreme difficulty in dissolving arsenic trioxide in anything other than a very basic solution, could be overcome by forming a much more soluble diarsenic tetraoxide, including the compound NaHAs2O4, prior to its delivery to a patient. Pharmaceutical compositions with such compounds and their use in the treatment of cancers is disclosed.
Patent NZ-756322-A (NZ)
Title: Mechanism of urea/solid acid interaction under storage conditions and storage stable solid compositions comprising urea and acid
Inventor: ANDERSON DERRICK
IPC: C11D3/20
Filed: 2018-03-01
Abstract: A stabilized solid composition comprising: a urea solidification matrix; an acid; and at least one additional active component comprising a surfactant, polymer, and/or additional solids, wherein the urea and the acid are in a preformed solid complex in a molar ratio from about 1:3 to about 3:1, and a use solution has a pH between about 2 to about 6. A method of cleaning, sanitizing and/or rinsing a surface. A method of making the solid composition, the method comprising: combining the urea and the acid in a solution; co-crystallizing the urea and the acid to form a solid complex; adding at least one additional active component comprising a surfactant, polymer, and/or additional solids to form a stable solid composition.
Patent PT-100560-A (PT)
IPC: C07K14/81
Filed: 1992-06-01
Abstract: The invention relates to the use of inhibitors of neutral Ca<2+> dependent proteinases (CANPs) and their pharmaceutically acceptable addition salts or their active subunits in the field of tumour therapy, especially cancer therapy, viral diseases therapy, AIDS therapy and contraception. The inhibitors can especially be used against protease bound glycosaminoglycan-substrate dependent tumours, viral diseases and contraception by selective malignant cell killing, viruses and spermatozoa killing and inhibiting of nuclear vlimmata in a host-parasite cell system involving common protease bound substrate. The inhibitors are heatstable, tetrameric proteins at neutral pH, approximatively 240 KDa, destroyed with trypsin. The pharmaceutical compositions may be prepared in a manner known per se, with carriers or additives commonly used in the pharmaceutical industry.
Patent PT-102803-A (PT)
Title: Kiosk type advertisement system with two recyclable 100 microns transparent polypropylene foils applied to e.g. magazines for protection and inscribed with advertisements
Inventor: ALVES ARMANDO LEITE
IPC: G09F1/10
Filed: 2002-07-04
Abstract: Kiosk type advertisement system with two recyclable 100 microns transparent polypropylene foils applied to e.g. magazines for protection and inscribed with advertisements
Patent PT-107249-A (PT)
Title: Junta de construção de transição suave entre lajes para pavimentos em betão com elementos superiores substituíveis
Inventor: GONÇALVES VIRGÍLIO DAVID LOPES
IPC: E01C11/02
Filed: 2013-10-21
Abstract: O PRESENTE INVENTO REFERE-SE A UMA JUNTA DE CONSTRUÇÃO PARA PAVIMENTOS INDUSTRIAIS EM BETÃO, ESPECIALMENTE APLICÁVEL EM LOCAIS ONDE É NECESSÁRIA UMA TRANSIÇÃO DE VEÍCULOS ENTRE AS LAJES SEM RESSALTOS E ONDE O PAVIMENTO É SUJEITO A UM TRÁFEGO MUITO INTENSO. É COMPOSTO POR UMA BARRA COM RECORTE ONDULADO LARGA (1) QUE SE ENCONTRA APARAFUSADA A UMA CANTONEIRA DE ABAS DESIGUAIS (4) COM PARAFUSOS DE CABEÇA DE EMBEBER (7) E UMA BARRA COM RECORTE ONDULADO ESTREITA (2) QUE ESTÁ APARAFUSADA A UMA CANTONEIRA DE ABAS IGUAIS (3) TAMBÉM COM PARAFUSOS DE CABEÇA DE EMBEBER (7). ESTES DOIS CONJUNTOS SÃO UNIDOS POR REBITES (11) ATRAVÉS DOS FUROS EXISTENTES NA LATERAL DAS CANTONEIRAS E A UNIÃO ENTRE DUAS JUNTAS CONSECUTIVAS É FEITA RECORRENDO AOS FUROS EXISTENTES NAS EXTREMIDADES DE AMBAS AS CANTONEIRAS UTILIZANDO-SE PARA TAL UM PARAFUSO EM PLÁSTICO (12) E UMA PORCA METÁLICA (13). SOLDADA À CANTONEIRA DE ABAS IGUAIS (3) ENCONTRA-SE UM PERFIL DE CHAPA (10) COM UMA FORMA SEMELHANTE À LETRA J QUE POSSUI A FUNÇÃO DE COFRAGEM E VAI DEFINIR A ORIENTAÇÃO DA JUNTA, ESTE PERFIL DE CHAPA (10) POSSUI RASGOS ONDE DESLIZA UMA CHAPA (14). O INVENTO É APLICÁVEL, POR EXEMPLO, NA CONSTRUÇÃO DE ARMAZÉNS DE LOGÍSTICA, ONDE SEJAM ARMAZENADOS PRODUTOS FRÁGEIS.
Patent RU-94024981-A (RU)
Inventor: GUSTOMESOV V A
IPC: B23C3/12
Filed: 1994-07-04
Abstract: FIELD: production of cold rolled metallic strips. SUBSTANCE: method providing enhanced stability of strips edges at working and enhanced conditions of operation of tool in the form of disc due to lowered possible vibration of moved strip involves working the ends of edges by tools whose rotation axis are inclined relative to curves of profiles of the ends in the direction of motion of the material; before working optimal width of the edges is set and then they are processed uniformly at automatic tracing of cross shift of the strip. EFFECT: enhanced quality of edge working and improved conditions of tool operation.
Patent RU-94025151-A (RU)
Inventor: FROLOV M A
IPC: A61F9/013
Filed: 1994-07-04
Abstract: FIELD: ophthalmology, particularly, sectorial keratoplasty. SUBSTANCE: method involves forming two nonthrough interlayered and opposite-oriented canals in corneal stroma to depth 0.2 to 0.4 mm, through which sharp-edged band implants with appropriate cross-section are introduced. EFFECT: reducing traumatism during operative intervention, saving toughness of eye cornea, and prevention of such complication as epithelium growing into cornea.